PHARMACODYNAMICS AND PHARMACOKINETICS OF DRUGS USED IN PNEUMONIA

The prevalence of infectious diseases of the respiratory system and, first of all, pneumonia among the population, the presence of various etiological factors and conditions for the appearance of diseases, doctors of various specialties - therapists, surgeons, neuropathologists - predetermine the occurrence of this disease. Faced with this pathology. Few or atypical clinical signs characteristic of the modern course of pneumonia complicate the diagnosis and complicate the treatment of the patient. The presence of diseases accompanied by decompensation against the background of an infectious lung lesion worsens the prognosis and increases the risk of death. It is especially important to correctly diagnose infectious lung disease in time and to prescribe adequate antibacterial therapy. Pneumonia is a group of acute infectious diseases of different etiology and pathogenesis, characterized by focal damage of the respiratory parts of the lungs and the presence of alveolar exudation (see picture). Modern classification defines the following types of pneumonia: 1) community-acquired - CP (ambulatory) - acquired outside a medical institution; 2) nosocomial (hospital, in-hospital) - acquired in a medical institution; 3) aspiration; 4) pneumonia in people with severe immune deficiencies - pneumonia caused by congenital immunodeficiency, HIV infection, iatrogenic immunosuppression. This division is based on the difference in the conditions in which the disease occurs and the approaches to the selection of antimicrobial therapy. Among registered pneumonias, the most common is CAP (ambulatory).